Skip to search formSkip to main contentSkip to account menu

HMR 3647

Known as: HMR-3647, HMR3647 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Functional Escherichia coli 50S ribosomal subunits can be reconstituted from their natural rRNA and protein components. However… 
2002
2002
The new ketolide antibiotic telithromycin (HMR3647) has been examined for inhibitory effects in cells of Streptococcus pneumoniae… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT The activity of a new ketolide, ABT-773, was compared to the activity of the ketolide telithromycin (HMR-3647) against… 
Review
2001
Review
2001
Recent semi-synthetic studies of erythromycin A culminated in the discovery of two ketolide drug candidates, HMR-3647 and ABT-773… 
2001
2001
ABSTRACT The in vivo activity of telithromycin against erythromycin A- and penicillin G-resistant Streptococcus pneumoniae was… 
2000
2000
ABSTRACT The in vitro activity of telithromycin (HMR3647), a new ketolide, against Mycoplasma pneumoniae was determined by the… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT Testing of susceptibility to 13 antibiotics was performed with 90 isolates of Lactobacillus, Leuconostoc, andPediococcus… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT The activities of HMR 3647, HMR 3004, erythromycin, clarithromycin, and levofloxacin for 97 Legionella spp. isolates… 
Highly Cited
1999
Highly Cited
1999
ABSTRACT HMR3647 is a semisynthetic representative of a new group of drugs, the ketolides, derived from erythromycin A. Since… 
1998